Therapeutic device for sweattube tumor

Abstract

The invention discloses a sweattube tumor treatment device which comprises a treatment body and a switch installed on the treatment body. A treatment head located at the head of the treatment body; the ultrasonic imaging module is used for obtaining a sweattube tumor ultrasonic image comprising the thickness of the sweattube tumor; the needle insertion depth determining module is used for determining the needle insertion depth of the electrolytic needle according to the thickness of the sweatnoma output by the ultrasonic imaging module; the treatment time determining module is used for determining treatment time according to the thickness of the sweating duct tumor output by the ultrasonic imaging module; the image acquisition module is used for acquiring sweat duct tumor images; the treatment current determining module is used for determining a treatment current according to the sweating duct tumor image acquired by the image acquisition module; the control module is used for sending out a control instruction for generating and outputting pulse treatment current according to the determined treatment time and treatment current; and the pulse current generation module is used for generating and outputting treatment pulse current to the treatment head according to a control instruction for generating and outputting pulse treatment current.

Description

Technical Field

[0001] The present invention relates to the field of electrolysis treatment, in particular to a syringoma treatment device capable of determining treatment time and treatment current intensity according to the condition of the disease. Background Art

[0002] The syringoma treatment device is a physical therapy device that selectively destroys syringoma tissue through the heat energy generated by high-frequency electric current. Its principles are as follows: 1. Thermal effect destruction: The high-frequency electric current needle tip contacts the syringoma tissue, instantly generating high temperatures (up to hundreds of degrees Celsius), causing the tumor cell proteins to denature and coagulate, ultimately leading to carbonization and necrosis. 2. Precision: By controlling the current intensity and operation time, it can precisely act on the tumor, reducing damage to surrounding normal tissue. It is especially suitable for sensitive areas such as the eyelids. 3. Destruction of blood vessels and ducts: The thermal energy of the electric current can also destroy the capillaries and abnormal sweat gland ducts in the tumor, blocking the nutrient supply and inhibiting tumor regeneration.

[0003] The syringoma treatment device is mainly suitable for small, dense, and superficial syringomas, especially in areas of the eyelids and face that are difficult to cover with traditional lasers.

[0004] After 1-3 treatments, most patients experience complete detachment of the tumor and a smooth return to the skin surface. Studies have shown that if the procedure is thorough, the recurrence rate is low.

[0005] Compared with surgical resection, electrolysis is less invasive and has a lower risk of postoperative scarring. It is suitable for patients who have high requirements for appearance and can relieve the itching or local irritation symptoms associated with syringoma.

[0006] Some patients, due to deep or densely distributed tumors, require multiple procedures (4-8 weeks apart) to ensure complete removal. After electrolysis, the wound surface must be kept clean to avoid infection, and sun protection should be applied to minimize pigmentation.

[0007] Compared to traditional continuous current, pulsed current (non-continuous, intermittent high-frequency current) is more controllable and precise in syringoma treatment. Its core mechanisms of action include selective thermal damage and controlled intermittent energy release to reduce cumulative thermal effects. Pulsed current uses an alternating "on-off" pattern to prevent the spread of heat energy caused by continuous heat generation. Each pulse releases energy only for a very short time (microseconds to milliseconds), concentrating heat on the syringoma tissue and reducing the risk of burns to surrounding normal tissue.

[0008] High-intensity pulsed current can induce transient micropores in cell membranes (electroporation), leading to ion imbalances inside and outside the cells, disrupting the metabolic environment of syringoma cells and accelerating their death. The low thermal diffusion properties of pulsed current make it safe for use on areas like the eyelids and nose, avoiding scarring.

[0009] Syringomas in dermatology currently account for 2%-10% of vascular lesions, currently treated with electrolysis (inserting a tiny needle into the syringoma and applying high-frequency current to generate high temperature and chemical reactions, thereby vaporizing the syringoma tissue and carbonizing the scab). Traditional treatment equipment relies on the doctor's naked eye to identify the lesion area, which carries the risk of missed diagnosis or positioning error. The treatment process relies on manual operation and has a low degree of automation. Parameters such as electrode insertion depth, current intensity, and action time need to be manually adjusted, and differences in operator experience can easily lead to unstable treatment effects. Lack of standardization leads to a large number of treatments and large individual differences, resulting in uneven treatment among patients.

[0010] Furthermore, as a common benign tumor of the skin's appendages, clinical diagnosis of syringomas relies primarily on visual observation and empirical judgment. However, because syringoma symptoms mimic a variety of skin conditions, such as flat warts and milia, misdiagnosis and missed diagnoses are common, adversely affecting patients' timely treatment and physical and mental health. Summary of the Invention

[0011] The purpose of the present invention is to provide a syringoma treatment device capable of determining the treatment time and treatment current intensity according to the condition of the disease.

[0012] According to a first embodiment of the present invention, a syringoma treatment device includes a treatment body, a switch installed on the treatment body; a treatment head located at the head of the treatment body; an ultrasonic imaging module for obtaining an ultrasonic image of the syringoma including the thickness of the syringoma; a needle insertion depth determination module for determining the insertion depth of an electrolysis needle according to the syringoma thickness output by the ultrasonic imaging module; a treatment time determination module for determining the treatment time according to the syringoma thickness output by the ultrasonic imaging module; an image acquisition module for acquiring syringoma images; a treatment current determination module for determining a treatment current according to the syringoma images acquired by the image acquisition module; a control module for issuing a control instruction for generating and outputting a pulse treatment current according to the determined treatment time and treatment current; and a pulse current generation module for generating and outputting a treatment pulse current to the electrolysis needle of the treatment head according to the control instruction for generating and outputting a pulse treatment current.

[0013] According to a second embodiment of the present invention, a syringoma treatment device includes a treatment body, a switch installed on the treatment body; a treatment head located at the head of the treatment body; an image acquisition module for acquiring images of the surface of the diseased skin; a syringoma and syringoma condition identification module for identifying syringomas based on the surface of the diseased skin acquired by the image acquisition module; an ultrasound imaging module for starting to acquire ultrasound images of the syringoma including the thickness of the syringoma based on the syringoma identification result output by the syringoma identification module; a needle insertion depth determination module for determining the insertion depth of an electrolytic needle based on the syringoma thickness output by the ultrasound imaging module; a treatment time determination module for determining the treatment time based on the syringoma thickness output by the ultrasound imaging module; a treatment current determination module for determining a treatment current based on the syringoma condition output by the syringoma identification module; a control module for issuing a control instruction for generating and outputting a pulse treatment current based on the determined treatment time and treatment current; and a pulse current generation module for generating and outputting a treatment pulse current to the electrolytic needle of the treatment head based on the control instruction for generating and outputting a pulse treatment current.

[0014] According to a third embodiment of the present invention, a syringoma treatment device includes a treatment body, a switch installed on the treatment body; a treatment head located at the head of the treatment body; an ultrasonic imaging module for obtaining an ultrasonic image of the syringoma including the thickness of the syringoma; a needle insertion depth determination module for determining the insertion depth of the electrolytic needle according to the syringoma thickness output by the ultrasonic imaging module; a pushing mechanism for controlling the electrolytic needle on the treatment head to be pushed out of the treatment head by a corresponding length according to the determined needle insertion depth; a treatment time determination module for determining the treatment time according to the syringoma thickness output by the ultrasonic imaging module; an image acquisition module for acquiring syringoma images; a treatment current determination module for determining the treatment current according to the syringoma images acquired by the image acquisition module; a control module for issuing a control instruction for generating and outputting a pulse treatment current according to the determined treatment time and treatment current; and a pulse current generation module for generating and outputting a treatment pulse current to the electrolytic needle of the treatment head according to the control instruction for generating and outputting the pulse treatment current.

[0015] According to a fourth embodiment of the present invention, a syringoma treatment device includes a treatment body, a switch mounted on the treatment body; a treatment head with treatment electrodes located at the head of the treatment body; an image acquisition module for acquiring images of the surface of the diseased skin; a syringoma recognition module for identifying syringomas and the condition of the syringoma based on the surface of the diseased skin acquired by the image acquisition module; an ultrasound imaging module for starting to acquire ultrasound images of the syringoma including the thickness of the syringoma based on the syringoma recognition result output by the syringoma recognition module; a needle insertion depth determination module for determining the insertion depth of an electrolytic needle based on the syringoma thickness output by the ultrasound imaging module; a pushing mechanism for controlling the electrolytic needle to be pushed out of the treatment head by a corresponding length based on the determined needle insertion depth; a treatment time determination module for determining the treatment time based on the syringoma thickness output by the ultrasound imaging module; a treatment current determination module for determining the treatment current based on the syringoma condition output by the syringoma recognition module; a control module for issuing a control instruction for generating and outputting a pulse treatment current based on the determined treatment time and treatment current; and a pulse current generation module for generating and outputting a treatment pulse current to the electrolytic needle of the treatment head based on the control instruction for generating and outputting a pulse treatment current.

[0016] The first to fourth embodiments of the present invention further include a display module for displaying the needle insertion depth, treatment time and treatment current.

[0017] Preferably, the ejection mechanism is a micro hydraulic mechanism or a micro electric push rod; the ejection mechanism controls the ejection mechanism to eject the electrolytic needle from the treatment head according to the needle insertion depth output by the needle insertion depth determination module and the corresponding relationship between the needle insertion depth and the ejection time.

[0018] Preferably, the treatment current determination module includes: a color extraction unit for extracting color features from the syringoma image; and a treatment current intensity unit for determining the magnitude of the treatment current according to the color features.

[0019] Preferably, the treatment current intensity unit searches a database for known syringoma treatment current intensities with the same color features according to the extracted color features, and uses the found current intensity as the treatment current.

[0020] Preferably, the treatment time determination module searches the database for a treatment time corresponding to the thickness of the syringoma as the syringoma treatment time.

[0021] Preferably, the syringoma identification module compares the syringoma contour features of the known syringoma skin surface sample image with the contour features of the lesion skin surface image, and identifies the syringoma as a syringoma if the two are the same.

[0022] Preferably, the syringoma recognition module identifies syringomas by inputting the denoised diseased skin surface image into a trained Transformer network.

[0023] This invention precisely adjusts the penetration depth by adjusting the pulse frequency and pulse width (the duration of a single pulse). High-frequency, short-width pulses (e.g., above 100kHz) primarily act on the epidermis and are suitable for superficial syringomas; low-frequency, long-width pulses can penetrate into the dermis and treat deeper lesions.

[0024] The pulse current generated by the present invention destroys syringoma while protecting normal tissue to the greatest extent. Its core advantages are that it is safer, more comfortable, and has a lower recurrence rate, and is especially suitable for patients with high requirements for aesthetics. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] Figure 1 is a schematic diagram of the appearance of a first embodiment of a syringoma treatment device according to the present invention;

[0026] Figure 2 This is one of the principle diagrams of the syringoma treatment device of the present invention;

[0027] Figure 3 This is the second schematic diagram of the syringoma treatment device of the present invention;

[0028] Figure 4a and Figure 4b They are schematic diagrams of a second embodiment of the appearance of a syringoma treatment device according to the present invention;

[0029] Figure 5 This is the third schematic diagram of the syringoma treatment device of the present invention;

[0030] Figure 6 This is the fourth schematic diagram of the syringoma treatment device of the present invention;

[0031] Figure 7 It is a schematic diagram of the treatment effect of the syringoma treatment device of the present invention. DETAILED DESCRIPTION

[0032] Figure 1 The first embodiment of the syringoma treatment device of the present invention is shown, comprising an ultrasonic imaging module 300, an image acquisition module 400, a display module 500, and a treatment body 100. The treatment body 100 is equipped with a switch 600 for turning on the power of the syringoma treatment device, and a treatment head 200. The treatment head 200 is equipped with one or more electrolysis needles 210, each of which has a positive electrode and a negative electrode, and is provided with a scale to indicate the depth of penetration into the skin. The ultrasonic imaging module 300, image acquisition module 400, and display module 500 can be mounted on or outside the treatment body 100. The image acquisition module 400 can be a camera module on a smartphone or a webcam.

[0033] Figure 2 The present invention is shown to be applicable to Figure 1The first embodiment of the syringoma treatment device shown includes an ultrasonic imaging module 300 for obtaining an ultrasonic image of a syringoma including its thickness; a needle insertion depth determination module 110 for determining the insertion depth of an electrolysis needle based on the syringoma thickness output by the ultrasonic imaging module 300; a treatment time determination module 120 for determining the treatment time based on the syringoma thickness output by the ultrasonic imaging module 300; an image acquisition module 400 for acquiring a syringoma image; a treatment current determination module 130 for determining a treatment current based on the syringoma image acquired by the image acquisition module 400; a control module 140 for issuing a control instruction for generating and outputting a pulsed treatment current based on the determined treatment time and treatment current; and a pulsed current generation module 150 for generating and outputting a treatment pulse current to the electrolysis needle 210 of the treatment head 200 based on the control instruction for generating and outputting a pulsed treatment current. Specifically, the pulsed current generation module 150 generates a pulsed current having a pulse width equal to the treatment time and a current intensity equal to the determined current intensity based on the control instruction.

[0034] See also Figure 2 The output of the ultrasound imaging module 300 is connected to the inputs of the needle insertion depth determination module 110 and the treatment time determination module 120. The output of the image acquisition module 400 is connected to the input of the treatment current determination module 130. The input of the control module 140 is connected to the outputs of the treatment current determination module 130 and the treatment time determination module 120. The output of the control module 140 is connected to the input of the pulse current generation module 150.

[0035] The input end of the display module 500 is connected to the output end of the needle insertion depth determination module 110 and the pulse current generation module 150 respectively, and is used to display the needle insertion depth, treatment time and treatment current respectively.

[0036] In one embodiment, the treatment current determination module 130 includes a color extraction unit that extracts color features from the syringoma image, specifically, extracts red, blue, and green pixels; and a treatment current intensity unit that determines the treatment current based on the color features. The treatment current intensity unit searches a database for known syringoma treatment current intensities with the same color features based on the extracted color features and uses the found current intensity as the treatment current.

[0037] The database of the present invention stores a large amount of known syringoma image data, whose color features correspond to verified treatment current intensities. Therefore, the treatment current intensity unit can obtain the verified effective treatment current intensity from the database based on the input image color features.

[0038] In another example, the treatment current determination module 130 may be a trained deep neural network that outputs the syringoma treatment current intensity based on the input image color features.

[0039] The database of the present invention also stores a verified correspondence table between syringoma thickness and treatment time. The treatment time determination module 120 can search the database for the treatment time corresponding to the syringoma thickness.

[0040] The present invention can identify the boundaries of syringomas and calculate their areas using edge detection algorithms (such as the Canny edge detector). Shape descriptors (such as the Hu moment) are used to quantify the shape characteristics of syringomas. Color space conversion (such as from RGB to HSV) and color histogram calculation are used to extract the color characteristics of syringomas.

[0041] The operating principle of the first embodiment of the present invention is as follows: after the switch 66 turns on the module's operating power, the ultrasonic imaging module 300 acquires an ultrasonic image of the syringoma thickness. The needle depth determination module 110 extracts syringoma thickness data from the ultrasonic image to determine the needle insertion depth. The display module 500 displays the needle insertion depth to guide the physician in inserting the electrolysis needle 210 into the patient's affected skin. The treatment time determination module 120 determines the treatment time based on the syringoma thickness. The image captured by the image acquisition module 400 is transmitted to the treatment current determination module 130, which determines the treatment current intensity based on the color characteristics of the image. Based on the received treatment time and treatment current intensity data, the control module 140 issues a control instruction to the pulse circuit generation module 150, causing it to generate a pulse current with a pulse width equal to the treatment time and a current intensity equal to or equivalent to the determined current intensity, and transmit the pulse current to the electrolysis needle 210.

[0042] Figure 7 The results show the therapeutic effect of treating syringoma using the syringoma treatment device of the present invention. Figure 7 The left column shows pre-treatment images; Figure 7 The image on the right column shows the syringoma on the eye significantly reduced three months after treatment.

[0043] Figure 3 Shows the applicable Figure 1 The second embodiment of the syringoma treatment device of the present invention shown includes an ultrasonic imaging module 300, an image acquisition module 400, a display module 500, and a treatment body 100. The treatment body 100 is equipped with a switch 600 for turning on the power of the syringoma treatment device, and a treatment head 200, which is equipped with one or more electrolysis needles 210.

[0044] See also Figure 3The second embodiment of the syringoma treatment device further includes: an image acquisition module 400 for acquiring images of the surface of the diseased skin; a syringoma and syringoma condition recognition module 160 for recognizing syringomas based on the images of the diseased skin surface acquired by the image acquisition module 400; an ultrasound imaging module 300 for acquiring ultrasound images of the syringoma including the thickness of the syringoma based on the syringoma recognition result output by the syringoma recognition module 160; a needle insertion depth determination module 110 for determining the insertion depth of the electrolysis needle based on the syringoma thickness output by the ultrasound imaging module 300; and a needle insertion depth determination module 110 for determining the insertion depth of the electrolysis needle based on the ultrasound imaging result. The treatment time determination module 120 determines the treatment time based on the syringoma thickness output by the image module 300; the treatment current determination module 130 determines the treatment current based on the syringoma condition (mild, moderate, or severe) output by the syringoma identification module 160; the control module 140 issues a control instruction for generating and outputting a pulsed treatment current based on the determined treatment time and treatment current; and the pulsed current generation module 150 generates and outputs a treatment pulse current to the electrolysis needles 210 of the treatment head 200 based on the control instruction for generating and outputting a pulsed treatment current. The pulsed current generation module 150 generates a pulsed current having a pulse width equal to the treatment time and a current intensity equal to or equivalent to the determined current intensity based on the control instruction.

[0045] See also Figure 3 The output of the image acquisition module 400 is connected to the input of the syringoma identification module 160. The two outputs of the syringoma identification module 160 are connected to the inputs of the ultrasound imaging module 300 and the treatment current determination module, respectively. The output of the ultrasound imaging module 300 is connected to the inputs of the needle insertion depth determination module 110 and the treatment time determination module 130, respectively. The outputs of the treatment current determination module 130 and the treatment time determination module 120 are connected to the inputs of the control module 140, respectively. The output of the control module 140 is connected to the input of the pulse current generation module 150.

[0046] The main difference between the second embodiment of the present invention and the first embodiment is that the syringoma identification module 160 determines whether the patient's skin lesion is a syringoma based on the skin lesion image and identifies the severity of the syringoma. The ultrasonic imaging module 300 and the treatment current determination module 130 operate based on the identification results of the syringoma identification module 160. In other words, the syringoma treatment device of the present invention will only operate if the syringoma identification module 160 determines that the patient's skin lesion is a syringoma. If the syringoma identification module 160 determines that the patient's skin lesion is not a syringoma, the ultrasonic imaging module 300, the needle insertion depth determination module 110, the treatment time determination module 130, and the pulse current generation module 150 all terminate their operations.

[0047] In one example, the syringoma identification module 160 compares the syringoma contour features of the known syringoma skin surface sample image with the contour features of the lesion skin surface image, and identifies the syringoma as a syringoma if the two are the same.

[0048] In another example, the syringoma identification module 160 identifies syringomas by inputting the denoised diseased skin surface image into a trained Transformer network.

[0049] The syringoma recognition method based on the Transformer network in the present invention can accurately extract the key features of syringoma images, improve the recognition accuracy of syringoma, and provide reliable technical support for doctors' clinical diagnosis.

[0050] The Transformer network can use the following modules:

[0051] Data Acquisition and Preprocessing: Using high-resolution skin image acquisition equipment, such as a professional dermatoscope or high-definition medical camera, skin image data from syringoma patients is collected under standard lighting conditions. The images collected should cover syringoma samples from different locations and stages of development. Preprocessing of the raw images includes image denoising, using a bilateral filtering algorithm to remove noise; image enhancement, using histogram equalization to increase image contrast; and image normalization, mapping image pixel values to a uniform range of [0, 1] to eliminate brightness variations caused by differences in acquisition equipment.

[0052] Image Blocking and Position Encoding Module: The preprocessed image is divided into multiple fixed-size blocks, each of which serves as the input to the Transformer network. A position code is added to each block, ensuring that it carries its position within the original image, allowing the Transformer network to understand the spatial relationship between blocks. The position code is generated using a combination of sine and cosine functions, added to the block's feature vector, and then fed into the Transformer network.

[0053] Transformer Feature Extraction Module: This module builds a feature extraction network based on the Transformer architecture, consisting of multiple Transformer blocks. Each Transformer block consists of a multi-head self-attention mechanism and a feed-forward neural network. In the multi-head self-attention mechanism, different attention heads concurrently calculate attention weights between image blocks, capturing the image's multi-scale features and global dependencies. The feed-forward neural network further performs nonlinear transformations and feature fusion on the features output by the self-attention mechanism, enhancing feature representation.

[0054] Feature Classification and Diagnosis Module: Syringoma image features extracted by the Transformer network are input into a classifier implemented using a fully connected neural network combined with a Softmax function. The fully connected neural network performs dimensionality reduction and nonlinear mapping on the features. The Softmax function converts the output feature vector into a probability distribution for each category, thereby determining whether the input image is a syringoma and identifying the type (e.g., eyelid type, eruptive type, etc.) and severity (mild, moderate, severe).

[0055] Model Training and Optimization Module: The aforementioned model is trained using a large dataset of labeled syringoma images. The cross-entropy loss function is used during training to measure the difference between the model's predictions and the true labels. The Adam optimizer is used to update model parameters, adjusting the learning rate and other hyperparameters. Through multiple iterations of training, the model converges to an optimal state, improving its recognition accuracy and generalization capabilities. For image classification training, the Dice loss function is used, defined as:

[0056]

[0057] Among them, y is the real mask, is the prediction mask, is the number of pixels of the intersection, |y| and are the number of pixels in the true mask and the predicted mask, respectively, and ∈ is a small smoothing term to avoid the denominator being zero.

[0058] The present invention solves the problems of traditional image recognition technology in processing syringoma images, such as incomplete feature extraction and limited ability to learn complex image features.

[0059] Figure 4a and Figure 4b The second embodiment of the syringoma treatment device of the present invention is shown. Figure 4a In the process, the electrolysis needle 210 is retracted into the treatment head 200. Figure 4b In FIG. 2 , the electrolysis needle 210 extends from the treatment head 200 .

[0060] Figure 5 Shows the applicable Figure 4a and Figure 4b The third embodiment of the syringoma treatment device of the present invention includes a treatment body 100, a switch 600 mounted on the treatment body, and a treatment head 200 with an electrolysis needle 210 located at the head of the treatment body.

[0061] The third embodiment of the present invention further includes: an ultrasonic imaging module 300 for obtaining an ultrasonic image of a syringoma including its thickness; a needle insertion depth determination module 110 for determining an insertion depth of an electrolytic needle according to the syringoma thickness output by the ultrasonic imaging module 300; a pushing mechanism 230 for controlling an electrolytic needle on a treatment head 200 to be pushed out of the treatment head 200 by a corresponding length according to the determined needle insertion depth; a treatment time determination module 120 for determining a treatment time according to the syringoma thickness output by the ultrasonic imaging module 300; an image acquisition module 400 for acquiring a syringoma image; a treatment current determination module 130 for determining a treatment current according to the syringoma image acquired by the image acquisition module 400; a control module 140 for issuing a control instruction for generating and outputting a pulse treatment current according to the determined treatment time and treatment current; a pulse current generation module 150 for generating and outputting a treatment pulse current to the treatment head 200 according to the control instruction for generating and outputting a pulse treatment current; and a display module 500 for displaying the needle insertion depth, treatment time, and treatment current.

[0062] The main difference between the third embodiment of the present invention and the first embodiment is that the treatment head 200 is equipped with an ejection mechanism 230, and the electrolysis needle 210 is mounted on the propulsion mechanism 230. The needle insertion depth determination module 110 transmits the needle insertion depth data to the treatment head 200; based on the needle insertion depth data, the treatment head 200 controls the ejection mechanism 230 to move a corresponding distance, thereby ejecting the electrolysis needle 210 from the treatment head 200.

[0063] The ejection mechanism 230 can be a micro hydraulic mechanism (hydraulic cylinder) or a micro electric push rod; the ejection mechanism 230 controls the ejection mechanism 230 to eject the electrolysis needle 210 from the treatment head 200 according to the needle insertion depth output by the needle insertion depth determination module 110 and the corresponding relationship between the needle insertion depth and the ejection time.

[0064] The advantage of the third embodiment of the present invention is that the electrolysis needle 210 can be automatically inserted into the syringoma cortex according to the determined needle insertion depth. The medical staff only needs to Figure 4a The treatment head 200 shown is placed on the skin surface, and the pushing mechanism 230 can insert the electrolysis needle 210 in the treatment head 200 into the root of the syringoma, thereby improving the treatment efficiency.

[0065] Figure 6 Shows the applicable Figure 4a and Figure 4b The fourth embodiment of the syringoma treatment device of the present invention includes a treatment body 100, a switch 600 mounted on the treatment body, and a treatment head 200 located at the head of the treatment body and having one or more electrolysis needles 210.

[0066] The fourth embodiment of the present invention further includes an image acquisition module 400 for acquiring images of the surface of the diseased skin; a syringoma identification module 160 for identifying syringomas and the severity of the syringoma based on the images of the diseased skin surface acquired by the image acquisition module 400; an ultrasound imaging module 300 for acquiring ultrasound images of the syringoma, including the thickness of the syringoma, based on the syringoma identification results output by the syringoma identification module 160; a needle insertion depth determination module 110 for determining the insertion depth of the electrolysis needle based on the syringoma thickness output by the ultrasound imaging module 300; and a pushing mechanism for controlling the electrolysis needle to be pushed out of the treatment head 200 to a corresponding length based on the determined insertion depth. 230; a treatment time determination module 120 for determining the treatment time according to the syringoma thickness output by the ultrasonic imaging module 300; a treatment current determination module 130 for determining the treatment current according to the syringoma condition output by the syringoma identification module 160; a control module 140 for issuing a control instruction for generating and outputting a pulse treatment current according to the determined treatment time and treatment current; a pulse current generation module 150 for generating and outputting a treatment pulse current to the treatment head 200 according to the control instruction for generating and outputting a pulse treatment current; and a display module 500 for displaying the needle insertion depth, treatment time and treatment current.

[0067] The main difference between the fourth embodiment of the present invention and the third embodiment is that the syringoma identification module 160 determines whether the patient's skin lesion is a syringoma based on the skin lesion image and identifies the severity of the syringoma. The ultrasonic imaging module 300 and the treatment current determination module 130 operate based on the identification results of the syringoma identification module 160. In other words, the syringoma treatment device of the present invention only operates when the syringoma identification module 160 determines that the patient's skin lesion is a syringoma. If the syringoma identification module 160 determines that the patient's skin lesion is not a syringoma, the ultrasonic imaging module 300, the needle insertion depth determination module 110, the treatment time determination module 130, and the pulse current generation module 150 all terminate their operations.

[0068] In summary, the present invention can conduct in-depth analysis on identified syringomas to understand their nature, severity, etc. The analysis results can be presented to patients or doctors in an intuitive manner so that doctors can identify syringomas.

[0069] In addition, the present invention can automatically adjust the current intensity and treatment time of electrolysis treatment and the electrode insertion depth according to the severity of the syringoma, thereby ensuring the accuracy and effectiveness of the treatment.

[0070] Although the present invention has been described in detail above, it is not limited thereto, and those skilled in the art can make various modifications based on the principles of the present invention. Therefore, any modifications made based on the principles of the present invention should be understood to fall within the scope of protection of the present invention.

Claims

1. A syringoma treatment device, comprising a treatment body (100), a switch (600) mounted on the treatment body; a treatment head (200) located at the head of the treatment body, characterized in that Also includes: An ultrasound imaging module (300) for obtaining an ultrasound image of a syringoma including the thickness of the syringoma; a needle insertion depth determination module (110) for determining the insertion depth of the electrolysis needle according to the syringoma thickness output by the ultrasonic imaging module (300); a treatment time determination module (120) for determining treatment time according to the syringoma thickness output by the ultrasonic imaging module (300); An image acquisition module (400) for acquiring syringoma images; a therapeutic current determination module (130) for determining a therapeutic current based on the syringoma image acquired by the image acquisition module (400); a control module (140) for issuing a control instruction for generating and outputting a pulsed therapeutic current according to the determined therapeutic time and therapeutic current; A pulse current generating module (150) generates and outputs a treatment pulse current to a treatment head (200) according to a control instruction for generating and outputting a pulse treatment current.

2. A syringoma treatment device, comprising a treatment body (100), a switch (600) mounted on the treatment body; a treatment head (200) located at the head of the treatment body, characterized in that Also includes: An image acquisition module (400) for acquiring images of the surface of diseased skin; A syringoma and syringoma condition recognition module (160) for identifying syringoma based on the diseased skin surface captured by the image acquisition module (400); An ultrasound imaging module (300) starts acquiring an ultrasound image of the syringoma including the thickness of the syringoma according to the syringoma identification result output by the syringoma identification module (160); a needle insertion depth determination module (110) for determining the insertion depth of the electrolysis needle according to the syringoma thickness output by the ultrasonic imaging module (300); a treatment time determination module (120) for determining treatment time according to the syringoma thickness output by the ultrasonic imaging module (300); a treatment current determination module (130) for determining a treatment current according to the syringoma condition output by the syringoma identification module (160); a control module (140) for issuing a control instruction for generating and outputting a pulsed therapeutic current according to the determined therapeutic time and therapeutic current; A pulse current generating module (150) generates and outputs a treatment pulse current to a treatment head (200) according to a control instruction for generating and outputting a pulse treatment current.

3. A syringoma treatment device, comprising a treatment body (100), a switch (600) mounted on the treatment body; a treatment head (200) located at the head of the treatment body, characterized in that Also includes: An ultrasound imaging module (300) for obtaining an ultrasound image of a syringoma including the thickness of the syringoma; a needle insertion depth determination module (110) for determining the insertion depth of the electrolysis needle according to the syringoma thickness output by the ultrasonic imaging module (300); A pushing mechanism (230) controls the electrolysis needle on the treatment head (200) to push out a corresponding length from the treatment head (200) according to the determined needle insertion depth; a treatment time determination module (120) for determining treatment time according to the syringoma thickness output by the ultrasonic imaging module (300); An image acquisition module (400) for acquiring syringoma images; a therapeutic current determination module (130) for determining a therapeutic current based on the syringoma image acquired by the image acquisition module (400); a control module (140) for issuing a control instruction for generating and outputting a pulsed therapeutic current according to the determined therapeutic time and therapeutic current; A pulse current generating module (150) generates and outputs a treatment pulse current to a treatment head (200) according to a control instruction for generating and outputting a pulse treatment current.

4. A syringoma treatment device, comprising a treatment body (100), a switch (600) mounted on the treatment body; a treatment head (200) with treatment electrodes located at the head of the treatment body, characterized in that Also includes: An image acquisition module (400) for acquiring images of the surface of diseased skin; a syringoma identification module (160) for identifying syringoma and the condition of syringoma based on the diseased skin surface acquired by the image acquisition module (400); An ultrasound imaging module (300) starts acquiring an ultrasound image of the syringoma including the thickness of the syringoma according to the syringoma identification result output by the syringoma identification module (160); a needle insertion depth determination module (110) for determining the insertion depth of the electrolysis needle according to the syringoma thickness output by the ultrasonic imaging module (300); A pushing mechanism (230) for controlling the electrolysis needle to be pushed out of the treatment head (200) to a corresponding length according to the determined needle insertion depth; a treatment time determination module (120) for determining treatment time according to the syringoma thickness output by the ultrasonic imaging module (300); a treatment current determination module (130) for determining a treatment current according to the syringoma condition output by the syringoma identification module (160); a control module (140) for issuing a control instruction for generating and outputting a pulsed therapeutic current according to the determined therapeutic time and therapeutic current; A pulse current generating module (150) generates and outputs a treatment pulse current to a treatment head (200) according to a control instruction for generating and outputting a pulse treatment current.

5. The syringoma treatment device according to any one of claims 1 to 4, further comprising a display module (500) for displaying needle insertion depth, treatment time and treatment current.

6. A syringoma treatment device according to claim 2 or 4, wherein the ejection mechanism (230) controls the ejection mechanism (230) to eject the electrolytic needle from the treatment head (200) according to the needle insertion depth output by the needle insertion depth determination module (110) and the corresponding relationship between the needle insertion depth and the ejection time.

7. The syringoma treatment device according to claim 1 or 3, wherein the treatment current determination module (130) comprises: a color extraction unit that extracts color features from syringoma images; A treatment current intensity unit determines the magnitude of the treatment current according to the color characteristics.

8. The syringoma treatment device according to claim 7, wherein the treatment current intensity unit searches a database for a known syringoma treatment current intensity with the same color feature according to the extracted color feature, and uses the found current intensity as the treatment current.

9. A syringoma treatment device according to any one of claims 1 to 4, wherein the treatment time determination module (120) searches a database for a treatment time corresponding to the thickness of the syringoma as the syringoma treatment time.

10. A syringoma treatment device according to claim 2 or 4, wherein the syringoma identification module (160) identifies syringoma by inputting the denoised diseased skin surface image into a trained Transformer network.

Images